LhARA is a Laser hybrid Accelerator for Radiobiological Applications in which laser interactions drive the creation of a large flux of protons or light ions.

LhARA is a Laser hybrid Accelerator for Radiobiological Applications in which laser interactions drive the creation of a large flux of protons or light ions.
A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.
A cellular therapy to locally deliver nitric oxide (NO) to the conventional aqueous humour outflow pathway, thereby lowering eye pressure and preserving vision in glaucoma.
anti-TCRVbeta Chimeric Antigen Receptors which can target pathological T cells in a highly selective manner, leaving >90% of the patient’s T cells and T cell-dependent immunity intact.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.